We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients with uncontrolled gout had additional burdens ...

Patients with gout are more likely than those without to initiate chronic opioid use. Patients with gout are more likely than those without to initiate chronic opioid use, according to study results ...

BLOOM (TAMPA) – Nephrologist Jason B. Rothschild, MD, recently joined Gayle Guyardo, the host of the globally syndicated health and wellness show Bloom, to discuss the often-overlooked connection ...

The MarketWatch News Department was not involved in the creation of this content. -- Results of a Phase 2a dose escalating study of lingdolinurad (ABP-671) for chronic gout, which enrolled patients ...

PHILADELPHIA — Although rare, hypercalcemia should be treated as a potential threat for patients with from severe tophaceous gout, according to a case study presented at the ASN Kidney Week. The case ...

Gout Prevalent in German CKD Cohort In an observational UK study, chronic kidney disease stage 3 or higher was 78% more likely to develop in patients with vs without gout during a median follow-up of ...

WATERTOWN, Mass., June 12, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based ...

Out-of-control chronic gout is characterized by painful symptoms that can negatively impact quality of life. The most common symptoms include intense joint pain, lingering discomfort, swelling, ...

Veterans with gout were 30% more likely to be prescribed chronic opioid therapy than those without gout, with factors such as female sex, underweight BMI, current smoking status, and a higher burden ...

JIANGSU, China--(BUSINESS WIRE)--Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing new treatments for inflammatory and metabolic ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech ...

Results of a Phase 2a dose escalating study of lingdolinurad (ABP-671) for chronic gout, which enrolled patients with mild to moderate renal impairment, showed the URAT1 inhibitor lowered serum uric ...